Search results for: Health Policy and Regulation
Filter search results
Why are Mortality Rates Rising for Middle-Aged White Non-Hispanic Americans? Could it Happen in Europe? 24th Annual Lecture Publication
19 March 2018
…which was published in a series of papers by Professors Case and Deaton in 2015 and 2017, has demanded serious contemplation from policymakers and researchers. For the 24th OHE Annual…
Can a Strong Economic Case Be Made for Investing in the NHS? 25th Annual Lecture Publication
2 January 2019
…financial system; structural reforms to increase employment, productivity, growth, and international competitiveness; and supporting societal wellbeing. In responding to the scepticism about the value of health spending, serious reconsideration needs…
Hospital Costs in Perspective
1 June 1963
Rising hospital costs have caused concern to the public, Government, and Members of Parliament ever since the start of the National Health Service. They are at present taxing the minds…
Projecting Expenditure on Medicines in the NHS
4 January 2013
…in the medicines market, e.g. the appearance of new products and the debut of new generics and biosimilars. The calculations in this study also differ from other estimates by using…
Efficiency in the Hospital Service
7 January 1967
…brief summary of hospital costs and how they have developed since the inception of the National Health Service is necessary in order to put the need for efficiency into perspective….
Value Based Pricing in Sweden: Lessons for Design?
11 January 2012
…health sector and emphasises both encouraging innovation and enhancing access through such options… In this Seminar Briefing, Ulf Persson recounts Sweden’s experience with its approach to value based pricing (VBP)….
Assessing the Performance of the EQ-VAS in the NHS PROMs Programme
1 April 2012
…health before and after surgery are being used as one indicator of hospital performance. The data also are being used by commissioners in evaluating the effectiveness and cost effectiveness of…
Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?
1 February 2011
This paper examines the potentially positive impact of differential pricing in Europe and the overall negative effects of international reference pricing (IRP) measures. The authors point out that IRP actually…
Estimating Pharmaceutical Companies’ Value to the Nation: Case Study of the British Pharma Group
1 February 2007
Share this: Download publication Martina Garau Knowing the net value that companies, or whole sectors of the economy, bring is clearly important when considering economic and industrial policy. In this…